A.µ¨²¿½áʯ B.µ¨ÄÒ½áʯ C.µ¨µÀ½áʯ D.µ¨Ç»½áʯ
66.ͨ¹ýͬÒå´Ê²éѯ¿ÉÖª£ºµ¨ÄÒÑ׵ĵÄͬÒå´ÊÊÇ£¨ £©¡££¨1·Ö£© A.½áʯÐÔµ¨ÄÒÑ× B.¼±ÐÔµ¨ÄÒÑ× C.ÂýÐÔµ¨ÄÒÑ× D.µ¨ÄÒ½áʯ
67.άÆÕÊý¾Ý¿âÖеĶþ´Î¼ìË÷¡°ÔÚ½á¹ûÖÐÌí¼Ó¡±´ú±í£¨ £©¡£ A.Âß¼Óë B.Âß¼»ò C.Âß¼·Ç D.ÖØмìË÷
68.£¨ £©Êý¾Ý¿âÓв鿴ͬÒå´Ê¹¦ÄÜ¡££¨1·Ö£© A.άÆÕ B.CNKI C.CBM D.Íò·½
69.ÒÔÏÂÊý¾Ý¿âÖмìË÷ÀúÊ·¿ÉÒÔ×éÅä¼ìË÷µÄÊÇ£¨1·Ö£© A.CNKI B.άÆÕ C.Íò·½ D.¶¼²»Ö§³Ö
70.Òª¼ìË÷²¢ÏÂÔØ×î½ü¼¸ÄêµÄÖлªÒ½Ñ§»áÆÚ¿¯ÎÄÏ×£¬Ó¦¸ÃÑ¡Ôñ£¨ £©Êý¾Ý¿â¡£ A.άÆÕ B.CNKI C.CBM D.Íò·½
71.Ñ֤ҽѧ¾ÍÊÇ£¨ £©£¨1·Ö£© A.ϵͳÆÀ¼Û
B.×î¼ÑÖ¤¾Ý¡¢ÁÙ´²¾ÑéºÍ²¡È˼ÛÖµµÄÓлú½áºÏ C.ÁÙ´²Á÷Ðв¡Ñ§ D.²éÕÒÖ¤¾ÝµÄҽѧ
72.Ñ֤ҽѧʵ¼ùµÄºËÐÄÊÇ£¨ £©¡££¨1·Ö£© A.²¡È˵ĺÏ×÷ B.Ò½ÉúµÄ¾Ñé
C.×î¼ÑµÄÑо¿Ö¤¾Ý
D.ÁÙ´²Á÷Ðв¡Ñ§µÄ»ù±¾·½·¨ºÍ֪ʶ
73.ÁÙ´²Ñо¿Ö¤¾Ý¹ú¼ÊÉϽÏÓдú±íÐÔµÄÓУ¨ £©ÖÖÖ¤¾Ý·Ö¼¶±ê×¼£¨1·Ö£© A.9 B.10 C.11
D.12
74.Ñ֤ҽѧʵ¼ùµÄµÚÈý¸ö²½ÖèÊÇ£¨ £© A.ϵͳȫÃæµÄ²éÕÒÖ¤¾Ý B.È·¶¨ÐèÒª½â¾öµÄÁÙ´²ÎÊÌâ C.Ó¦ÓÃ×î¼ÑÖ¤¾ÝÖ¸µ¼ÁÙ´²¾ö²ß D.ÑϸñÆÀ¼Û£¬ÕÒ³ö×î¼ÑÖ¤¾Ý 75.ÒÔÏÂÄĸö²»ÊÇCochrane LibraryµÄsearch limitsÀïµÄ¹ýÂËÌõ¼þ£¨£©¡££¨1·Ö£© A.Cochrane Reviews B.Author
C.Other Reviews D.Methods Studies
76.Cochrane LibraryµÄ¼ìË÷½á¹û²»¿ÉÒÔͨ¹ý£¨ £©·½Ê½ÅÅÐò¡£ A.Relevance:high to low B.Relevance:low to high C.Alphabetical D.Date
E.First Author 77.ÔÚCochrane LibraryÊý¾Ý¿âÖУ¬°´Ñ§¿ÆÖ÷Ìâ½øÐÐä¯ÀÀ£¬ÏÂÁÐÄĸöÖ÷Ìâ²»°üº¬ÔÚÄÚ£¨ £©
A.Pediatric Disease B.Blood Disorders C.Cancer D.Wounds
78.ÔÚCochrane LibraryµÄ»ù±¾¼ìË÷ÀĬÈϼìË÷×ֶβ»°üÀ¨£¨ £©¡£ A.Title B.Abstract C.Keyword D.Author
79.ÔÚCochrane LibraryÊý¾Ý¿âÖУ¬ÏµÍ³ÌṩµÄ¼ìË÷ģʽ²»°üÀ¨£¨ £©¡£ A.»ù±¾¼ìË÷ B.¸ß¼¶¼ìË÷
C.¼ìË÷ʽ¹ÜÀíÆ÷ D.Ö÷Ìâ´Ê¼ìË÷
E.×Ô¶¯×ª»»Æ¥Åä¼ìË÷
80.¸ù¾ÝÅ£½ò´óѧÑ֤ҽѧÖÐÐıê×¼ÍƼöÇ¿¶È×î¸ßµÄÖ¤¾ÝÊÇ£¨ £©¡£ A.µ¥¸ö²¡Àý¶ÔÕÕÑо¿
B.ͬÖÊÐÔ²¡Àý¶ÔÕÕÑо¿µÄϵͳÆÀ¼Û C.¿ÉÐÅÇø¼äСµÄËæ»ú¶ÔÕÕʵÑé D.ͬÖÊÐÔËæ»ú¶ÔÕÕʵÑéµÄϵͳÆÀ¼Û
81.¡°Óÿ¹Äý¼ÁÓë²»Óÿ¹Äý¼ÁÏà±ÈÄܽµµÍ¼±ÐÔȱѪÐÔÄÔ×äÖл¼ÕßµÄÔ¶ÆÚËÀÍö»ò²Ð¼²µÄ·çÏÕÂ𣿡±¸Ã¿ÎÌâÖУ¬ÀûÓÃPICO¹¹½¨ÁÙ´²ÎÊÌ⣬ÔòPΪ£º£¨ £©¡£ A.½µµÍ¼±ÐÔȱѪÐÔÄÔ×äÖл¼ÕßµÄÔ¶ÆÚËÀÍö»ò²Ð¼²µÄ·çÏÕ B.¿¹Äý¼Á C.²»Óÿ¹Äý¼Á
D.¼±ÐÔȱѪÐÔÄÔ×äÖл¼Õß
82.½¨Á¢ÁÙ´²ÎÊÌâµÄ¹ú¼ÊͨÓÃPICOÔÔòÖУ¬I´ú±íʲô£¨£©¡£ A.¼²²¡
B.¶Ô±È¸ÉÔ¤»ò±©Â¶ C.¸ÉÔ¤ D.²¡ÈË
83.½¨Á¢ÁÙ´²ÎÊÌâµÄ¹ú¼ÊͨÓÃPICOÔÔòÖУ¬C´ú±íʲô£¨£©¡£ A.¼²²¡
B.¶Ô±È¸ÉÔ¤»ò±©Â¶ C.¸ÉÔ¤ D.²¡ÈË
84.ʵ¼ùÖ¸ÄϵÄÓ¢ÎÄÃû³ÆÊÇ( )¡££¨1·Ö£© A.RCT B.Review
C.Systematic Reviews D.Practice Guideline 85.ϵͳÆÀ¼ÛµÄÓ¢ÎÄÃû³ÆÊÇ£¨ £©¡£ A.RCT B.Review
C.Systematic Reviews D.Practice Guideline 86.Ëæ»ú¶ÔÕÕʵÑéµÄ¼ò³ÆÊÇ( )¡££¨1·Ö£© A.RCT B.Review
C.Systematic Reviews D.Practice Guideline 87.×ÛÊöµÄÓ¢ÎÄÃû³ÆÊÇ( )¡££¨1·Ö£© A.RCT B.Review
C.Systematic Reviews D.Practice Guideline 88.ÔÚCochrane LibraryÊý¾Ý¿âÖУ¬ÎÄÏס°Endothelin receptor antagonists for pulmonary arterial hypertension¡±Ò»¹²ÄÉÈëÁË£¨ £©¸öËæ»ú¶ÔÕÕÊÔÑé¡££¨1·Ö£© A.5 B.8 C.10 D.12
89.ÔÚCochrane LibraryÊý¾Ý¿âÖУ¬ÎÄÏס°Topical silver for treating infected wounds¡±µÄµÚÒ»×÷ÕßÊÇ£¨ £©¡££¨1·Ö£© A.Hester Vermeulen B.Jarne M van Hattem C.Marja N Storm-Versloot D.Dirk T Ubbink
90.ÔÚCochrane LibraryÊý¾Ý¿âÖУ¬ÀûÓÃÖ÷Ìâ´Ê¼ìË÷¡°Hypertension¡±£¬Æ丱Ö÷
Ìâ´Ê¿ÉÒÔÑ¡ÔñΪ£¨ £©£¨1·Ö£© A.Adverse Effects B.Poisoning
C.Ultrasonography D.Secondary
91.ÔÚCochrane LibraryÊý¾Ý¿âÖУ¬ÎÄÏס°Honey as a?topical?treatment?for?wounds¡±Óм¸¸ö×÷Õߣ¨ £©¡££¨1·Ö£© A.1 B.3 C.5 D.6
92. ÔÚCochrane LibraryÊý¾Ý¿âÖÐËÑË÷ÎÄÏס°ÔÚInternet-based interventions for the secondary prevention of coronary heart disease¡±£¬ÈëÑ¡¸Ã×÷Õß±ê×¼µÄʵÑéÓм¸¸ö£¨ £©¡££¨1·Ö£© A.Five trials B.Eleven trials C.Eighteen trials D.six
93.ÔÚCochrane LibraryÊý¾Ý¿âÖУ¬ÎÄÏס°Aloe vera?for?treating?acute and chronic?wounds¡±µÄÍøÂç³ö°æʱ¼äÊÇ£¨ £©¡££¨1·Ö£© A.2010 B.2011 C.2012 D.2013
94.ÔÚCochrane LibraryÊý¾Ý¿âÖУ¬ÏÂÃæÄÄƪÎÄÏ×ÌṩÃâ·ÑÈ«ÎÄ£¨ £©¡££¨1·Ö£© A.Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants
B.Timing of breast surgery in premenopausal breast cancer patients C.Centralisation of services for gynaecological cancer D.Selenium for preventing cancer 95.ÔÚCochrane LibraryÊý¾Ý¿âÖÐËÑË÷ÓйطÇСϸ°û·Î°©£¨ non-small cell lung cancer £©µÄ·ÅÉäÖÎÁÆ (radiotherapy) µÄÎÄÏ×£¬ÒªÇó¼ìË÷´Ê³öÏÖÔÚ±êÌâÖÐ,¶ÔÕÕÊÔÑéÓУ¨ £©Æª¡££¨1·Ö£© A.5 B.21 C.323 D.8
96.ÔÚCochrane LibraryÊý¾Ý¿âÖÐËÑË÷ÓйطÇСϸ°û·Î°©£¨ non-small cell lung cancer £©µÄ·ÅÉäÖÎÁÆ (radiotherapy) µÄÎÄÏ×£¬ÒªÇó¼ìË÷´Ê³öÏÖÔÚ±êÌâÖÐ,other reviewsÓУ¨ £©Æª¡£ A.5 B.21 C.323 D.8